𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetic studies of high-dose metoclopramide with and without forced diuresis

✍ Scribed by Ell, Ch. ;Braun, J. ;König, H. J. ;Domschke, S. ;Domschke, W.

Publisher
Springer-Verlag
Year
1985
Tongue
English
Weight
383 KB
Volume
63
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amelioration of cytotoxic-induced emesis
Amelioration of cytotoxic-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam
✍ Martin C. Palmer; Barry M. Colls 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 340 KB

A double-blind randomised controlled trial comparing the antiemetic effects of sublingual lorazepam combined with high-dose, short course metoclopramide (3 mg/kg) infused twice 3 h apart with or without i.v. dexamethasone is reported. Sixty patients receiving a total of 209 cycles of potentially sev

Continuous infusion of high-dose metoclo
Continuous infusion of high-dose metoclopramide: comparison of pharmacokinetically adjusted and standard doses for the control of cisplatin-induced acute emesis
✍ J. M. Brechot; J. P. Dupeyron; C. Delattre; Cl. Chastang; J. P. Laaban; J. Roche 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 461 KB

Metoclopramide was administered by continuous infusion to two groups each of 14 patients on chemotherapy, randomized to receive either doses adjusted to individual pharmacokinetic parameters or doses adjusted as usual to body weight. The mean plasma concentration at the end of the infusion in the ad

Improved control of cisplatin-induced em
Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients
✍ Mark G. Kris; Richard J. Gralla; Leslie B. Tyson; Rebecca A. Clark; David P. Kel 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 820 KB

A series of consecutive trials were undertaken to determine whether higher doses of intravenous metoclopramide and combinations of metoclopramide, dexamethasone, and diphenhydramine would improve antiemetic control or decrease treatment-related side effects in patients receiving cisplatin at 120 mg/